Comparison of PET/CT with conventional imaging modalities (USG, CECT) in evaluation of N0 neck in head and neck squamous cell carcinoma

Medical Journal Armed Forces India

Volumn 68, Issue 4, 2012, Pages 322-327

  Chauhan, Ashutosh ^a   Kulshrestha, Pranjal ^b   Kapoor, Brig Sanjay ^a   Singh, Harkirat ^c   Jacob, M J ^d   Patel, Maneel ^e   Ganguly, Manomoy ^f  

^a Department of Laboratory Medicine and Transfusion Medicine   (India)

^b Oncology Center AH (R and R)   (India)

^c Associated with Armed Forces Medical College   (India)

^d INHS Asvini Hospital   (India)

^e Navy Office   (India)

^f MILITARY HOSPITAL   (India)

Author keywords

CECT; N0 neck staging; PET CT; Ultrasound

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOHEXOL;

ADULT; AGED; ARTICLE; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPHADENOPATHY; MALE; NECK LYMPHADENOPATHY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ULTRASOUND;

EID: 84867138711     PISSN: 03771237     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mjafi.2012.02.012     Document Type: Article

References (27)

1. Zbären P, Nuyens M, Caversaccio M, Stauffer E. Elective neck dissection for carcinomas of the oral cavity: occult metastases, neck recurrences, and adjuvant treatment of pathologically positive necks. Am J Surg. 2006;191:756-760.
2. Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994;120:699-702.
3. Friedman M, Toriumi DM, Mafee MF. The role of computed tomographic scanning in evaluating the clinically negative neck. In: Fee WE, Goepfert H, Johns ME, et al., eds. Head and Neck Cancer, vol 2. Toronto, Ontario: Canada, Decker; 1990:138-144.
4. de Bondt RB, Nelemans PJ, Hofman PA, et al. Detection of lymph node metastases in head and neck cancer: a metaanalysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol. 2007;64:266-272.
5. Ng SH, Yen TC, Liao CT, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med. 2005;46:1136-1143.
6. Myers LL, Wax MK, Nabi H, Simpson GT, Lamonica D. Positron emission tomography in the evaluation of the N0 neck. Laryngoscope. 1998;108:232-236.
7. Civantos FJ, Gomez C, Duque C, et al. Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck. 2003;25:1-9.
8. Stoeckli SJ, Steinert H, Pfaltz M, Schmid S. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck. 2002;24:345-349.
9. Hyde NC, Prvulovich E, Newman L, Waddington WA, Visvikis D, Ell P. A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol. 2003;39:350-360.
10. Brouwer J, de Bree R, Comans EF, Castelijns JA, Hoekstra OS, Leemans CR. Positron emission tomography using [18F] fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior? Eur Arch Otorhinolaryngol. 2004;261:479-483.
11. Som PM, Curtin HD, Mancuso AA. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. Am J Roentgenol. 2000;174:837-844.
12. Spiro RH, Morgan GJ, Strong EW, Shah JP. Supraomohyoid neck dissection. Am J Surg. 1996;172:650-653.
13. van den Brekel MW, van der Waal I, Meijer CJ, Freeman JL, Castelijns JA, Snow GB. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope. 1996;106:987-991.
14. Conti PS, Lilien DL, Hawley K, Keppler J, Grafton ST, Bading JR. PET and [18F]-FDG in oncology:a clinical update. Nucl Med Biol. 1996;23:717-735.
15. Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G. PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol. 2009;70:382-392.
16. Menda Y, Graham MM. Update on 18Ffluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers. Semin Nucl Med. 2005;35:214-219.
17. Stokkel MP, ten Broek FW, Hordijk GJ, Koole R, van Rijk PP. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18 fluorodeoxyglucose positron emission tomography. Ann Surg. 2000;231: 229-234.
18. Seiwert TY, Salama JK, Vokes EE. The chemoradiation paradigm in head and neck cancer. Nat Clin Pract Oncol. 2007;4:156-171.
19. Woolgar JA. Pathology of the N0 neck. Br J Oral Maxillofac Surg. 1999;37:205-209.
20. van den Brekel MW, Castelijns JA, Stel HV, et al. Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology. 1991;180:457-461.
21. Richards PS, Peacock TE. The role of ultrasound in the detection of cervical lymph node metastases in clinically N0 squamous cell carcinoma of the head and neck. Cancer Imaging. 2007;7:167-178.
22. Fleming AJ, Smith SP, Saul CM. Impact of 18-F-2-Fluorodeozyglucose-positron emission tomography/computed tomography on previously untreated head and necak cancer patients. Laryngoscope. 2007;117:1173-1179.
23. Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M. FDG-PET: a possible prognostic factor in head and neck cancer. Br J Cancer. 2002.
24. Allal AS, Slosman DO, Kebdani T, Allaoua M, Lehmann W, Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F] fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys. 2004;59: 1295-1300.
25. Greven KM, Williams DW, McGuirt Sr WF, et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck. 2001;23:942-946.
26. Liao CT, Chang JT, Wang HM, et al. Preoperative [18F] fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys. 2009;74:1054-1061.
27. Kubicek GJ, Champ C, Fogh S, et al. FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol. 2010;2:19.